October 16, 2008
Andrew Olshan, PhD, professor and chair of the Epidemiology Department in the University of North Carolina at Chapel Hill Gillings School of Global Public Health, has been awarded a grant worth nearly $2.9 million from the National Cancer Institute to study the causes of neuroblastoma.

Olshan is also the leader of the Cancer Epidemiology Program of UNC Lineberger Comprehensive Cancer Center and research professor of otolaryngology/head and neck surgery in the UNC School of Medicine.

The most common cancer in babies, neuroblastoma develops from nerve cells found in several areas of the body and most commonly affects children aged 5 or younger.

The five-year study will investigate the disease’s causes, with a focus on mothers’ diets and supplemental vitamin intake during pregnancy. Previous studies have suggested that vitamin use may reduce the risk of this cancer by 40 percent. The new research also will examine genetic factors in parents and children that may influence vitamin metabolism and risk of cancer. Study participants will include neuroblastoma patients diagnosed at hospitals participating in the Children’s Oncology Group, a North American pediatric clinical trials group.

Dr. Siega-Riz

Dr. Siega-Riz
Dr. Fei Zou

Dr. Fei Zou

Olshan’s co-investigators in the public health school include Anna Maria Siega-Riz, PhD, associate professor in the Departments of Epidemiology and Nutrition, and Fei Zou, PhD, associate professor of Biostatistics.




Note: Olshan can be reached at (919) 966-7424 or andy_olshan@unc.edu.



Gillings Admissions: 233 Rosenau Hall, (919) 445-1170
Student Affairs: 263 Rosenau Hall, (919) 966-2499
Dean's Office: 170 Rosenau Hall, (919) 966-3215
Business and Administration: 170 Rosenau Hall, (919) 966-3215
Academic Affairs: 307 Rosenau Hall, (919) 843-8044
Inclusive Excellence: 207B Rosenau Hall, (919) 966-7430
Room Reservations

135 Dauer Drive
Chapel Hill, NC 27599-7400